Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus by Esposito, Marco et al.
Interventions for replacing missing teeth: augmentation
procedures of the maxillary sinus (Review)
Esposito M, Grusovin MG, Rees J, Karasoulos D, Felice P, Alissa R, Worthington HV,
Coulthard P
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2010, Issue 4
http://www.thecochranelibrary.com
Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
5BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
16DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iInterventions for replacing missing teeth: augmentation procedures of the maxillary sinus (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Interventions for replacing missing teeth: augmentation
procedures of the maxillary sinus
Marco Esposito1 , Maria Gabriella Grusovin1 , Jonathan Rees1, Dimitrios Karasoulos1 , Pietro Felice2, Rami Alissa1, Helen VWorthing-
ton3, Paul Coulthard1
1Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Manchester, Manchester, UK. 2Department of
Oral and Dental Sciences, University of Bologna, Bologna, Italy. 3Cochrane Oral Health Group, School of Dentistry, The University
of Manchester, Manchester, UK
Contact address: Marco Esposito, Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Manchester,
Higher Cambridge Street, Manchester, M15 6FH, UK. espositomarco@hotmail.com. marco.esposito@manchester.ac.uk.
Editorial group: Cochrane Oral Health Group.
Publication status and date: Edited (no change to conclusions), published in Issue 4, 2010.
Review content assessed as up-to-date: 6 January 2010.
Citation: Esposito M, Grusovin MG, Rees J, Karasoulos D, Felice P, Alissa R, Worthington HV, Coulthard P. Interventions for
replacing missing teeth: augmentation procedures of the maxillary sinus. Cochrane Database of Systematic Reviews 2010, Issue 3. Art.
No.: CD008397. DOI: 10.1002/14651858.CD008397.
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Insufficient bone volume is a common problem encountered in the rehabilitation of the edentulous posterior maxillae with implant-
supported prostheses. Bone volume is limited by the presence of the maxillary sinus together with loss of alveolar bone height. Sinus lift
procedures increase bone volume by augmenting the sinus cavity with autogenous bone and/or commercially available biomaterials.
Objectives
To determine whether and when augmentation of the maxillary sinus are necessary and which are the most effective augmentation
techniques for rehabilitating patients with implant-supported prostheses.
Search methods
The Cochrane Oral Health Group’s Trials Register, CENTRAL, MEDLINE and EMBASE were searched on 7th January 2010. Several
dental journals were handsearched. The bibliographies of review articles were checked, and personal references were searched. More
than 55 implant manufacturing companies were also contacted.
Selection criteria
Randomised controlled trials (RCTs) of different techniques and materials for augmenting the maxillary sinus for rehabilitation with
dental implants reporting the outcome of implant success/failure at least to abutment connection.
Data collection and analysis
Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were conducted independently
and in duplicate. Authors were contacted for any missing information. Results were expressed as random-effects models using mean
differences for continuous outcomes and odds ratios for dichotomous outcomes with 95% confidence intervals. The statistical unit of
the analysis was the patient.
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Main results
Ten RCTs out of 29 met the inclusion criteria. One trial of 15 patients evaluated implants 5 mm long with 6 mm diameter as an
alternative to sinus lift in bone with a residual height of 4 to 6mm.Nine trials with 235 patients compared different sinus lift techniques;
of these four trials (114 patients) evaluated the efficacy of platelet-rich plasma (PRP). Due to the variety of techniques evaluated, meta-
analysis was only possible of use of PRP for implant failure (two trials) and complications (three trials). No statistically significant
difference was observed.
Authors’ conclusions
Conclusions are based on few small trials, with short follow-up, and judged to be at high risk of bias. Therefore conclusions should be
viewed as preliminary and interpreted with great caution. It is still unclear when sinus lift procedures are needed. 5 mm short implants
can be successfully loaded in maxillary bone with a residual height of 4 to 6 mm but their long-term prognosis is unknown. Elevating
the sinus lining in presence of 1 to 5 mm of residual bone height without the addition of a bone graft may be sufficient to regenerate
new bone to allow rehabilitation with implant-supported prostheses. Bone substitutes might be successfully used as replacements for
autogenous bone. If the residual alveolar bone height is 3 to 6 mm a crestal approach to lift the sinus lining, to place 8 mm implants
may lead to fewer complications than a lateral window approach, to place implants at least 10 mm long. There is no evidence that PRP
treatment improves the clinical outcome of sinus lift procedures with autogenous bone or bone substitutes.
P L A I N L A N G U A G E S U M M A R Y
Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus
Sufficient bone quantity is required for dental implant placement. Bone quantity towards the back of the upper jaw may be insufficient
for dental implant placement because of the presence of the maxillary sinus, a natural cavity within the bone. This cavity may enlarge
following tooth loss. There are a number of techniques, termed sinus lift procedures, aimed at increasing bone quantity prior to implant
placement. These techniques utilise bone graft material, either the patients own bone (autogenous bone), a range of commercially
available materials (biomaterials) or a combination of the two.
Short implants (5 to 8 mm) may be as effective and cause fewer complications than longer implants placed using a more complex
technique. It is not clear that bone graft materials are needed or whether some bone graft materials are more effective than others.
Biomaterials might be used in place of autogenous bone. There is no evidence to suggest factors extracted from the patients blood
improve bone healing.
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B A C K G R O U N D
Missing teeth may result in a functional and cosmetic deficit and
have traditionally been replaced with dentures or bridges. Dental
implants offer an alternative, they are inserted into the jawbones
and used to support dental prostheses. Dental implants rely on
the maintenance of a direct structural and functional connection
between living bone and the implant surface, this is termed os-
seointegration and was first described by Brånemark (Brånemark
1977). Osseointegration has undoubtedly been one of the most
significant scientific breakthroughs in dentistry over the past 40
years.
Insufficient bone volume is a commonproblemencountered in the
rehabilitation of the edentulous posterior maxilla with implant-
supported prostheses. The bone available for implant placement
may be limited by the presence of the maxillary sinus together
with loss of alveolar bone height. Bone volume may be increased
by augmentation, commonly the sinus cavity is augmented with
autogenous bone or biomaterials or both. Procedures are variously
described in the literature as sinus lift, sinus augmentation, sinus
floor elevation or augmentation of atrophic maxillary sinus.
Implant placement may be combined with sinus augmentation as
a ’one-stage’ technique. Alternatively sinus augmentation may be
carried out at some time prior to implant placement, as a ’two-
stage’ technique which requires an additional surgical episode.
Techniques of sinus augmentation (sinus lift)
Boyne described the pre-prosthetic surgical technique of retro-
grade sinus augmentation, in some cases blade implants were
placed (Boyne 1980). The technique required a window to be pre-
pared in the lateral wall of the sinus via a buccal sulcus incision,
the mucosal lining was elevated to create a cavity into which par-
ticulate bone from the iliac crest was placed and allowed to heal
for about 6 months or more before placing the implants.
Tatum described five tissue incisions (crestal, palatal, split thick-
ness palatal, vertical and horizontal vestibular), three types of bone
access (crestal, buccal wall and Le Forte I), the use of autogenous
bone, allograft and alloplast. In addition Tatum described sinus
augmentation and implant placement as a one-stage and a two-
stage technique (Tatum 1986).
The technique, known as a lateral window sinus lift, is widely
used today and is considered reliable particularly when autogenous
bone is used (Wallace 2003; Del Fabbro 2004).
Summers described a less invasive one-stage technique for sinus
floor elevation with simultaneous implant placement called the
osteotome sinus floor elevation. Summers considered necessary at
least 6 mm of residual bone to ensure primary stability of the im-
plant. Concave tipped osteotomes of increasing diameter applied
via a crestal approach advanced a mass of bone beyond the level
of the original sinus floor, elevating the mucosal lining. Summers
combined this procedure with the addition of a bone graft material
(Summers 1994). For cases of less than 6mm residual bone height,
Summers proposed a two-stage approach. A bone plug is defined
with a trephine and displaced superiorly with the use of a broad
osteotome. Hydrostatic pressure elevates the mucosal lining of the
sinus. The resultant osteotomy is filled with a bone graft material
and the implant placed after a period of healing (Summers 1995).
Cosci modified the crestal approach technique utilising an atrau-
matic lifting drill to reduce the risk of perforation of the mucosa
lining the sinus using this one-stage technique with as little as 3
mm of residual bone (Cosci 2000). Bone can be collected with a
trephine directly from the osteotomy site to be used as grafting
material, a bone substitute can be used or the implant tip can hold
up the sinus membrane that will work as a natural barrier for bone
regeneration. While the crestal approach is less invasive and is a
one-stage technique, there are some disadvantages associated with
it. The amount of bone which can be gained using a crestal ap-
proach is usually less than that obtained with the lateral window
technique, and a minimum of 3 mm crestal bone height is gen-
erally recommended to stabilize the implant at placement (Cosci
2000).
In order to obtain simultaneous vertical bone augmentation with
a sinus lift procedure, Cannizzaro proposed a technique that is a
combination of a sinus lift and an onlay graft. Implants are placed
in the ulna, bone blocks containing the implants are retrieved with
a trephine, inserted into the sinus via a crestal approach and left
protruding occlusally for some mm in order to obtain simultane-
ous vertical bone gain (Cannizzaro 2007).
Materials used in sinus lift procedures
Autogenous bone has long been considered the gold standard
(Palmer 2000). Intra-oral donor sites (chin and ramus) are conve-
nient but yield limited volume. Extra-oral donor sites (iliac crest,
tibia, ulna, rib and calvarium) increase surgical complexity and
are associated with significant (and underreported) morbidity and
scarring.Therefore alternative graftingmaterials (bone substitutes)
have been developed.
Allografts consist of ’same species’ tissue. Cadaveric bone is har-
vested and various techniques (freeze drying and irradiation) re-
duce antigenicity. The grafts are then sterilised and supplied by
specially licensed tissue banks.
Xenografts consist of ’different species’ tissue. Anorganic bovine
and equine bone predominate. Chemical removal of the organic
component creates a mineral scaffold.
Alloplasts are synthetic bone substitutes. There are many types
classified in terms of porosity as dense, macro-porous, micro-
porous, and either crystalline or amorphous. The structure in-
fluences performance. Some examples are: beta tri-calcium phos-
phate, bio-active glass, calcium sulphate.
All these graft materials can be delivered in various convenient
forms such as bone particles or large blocks, can be mixed with
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autogenous bone and can be very stable over time or highly re-
sorbable, depending on their chemical characteristics.
Urist discovered that cell free, decalcified bone implanted into ex-
tra-skeletal sites stimulated new bone formation (Urist 1965). The
biologically active molecules responsible belong to the growth fac-
tor B family and are called bone morphogenetic proteins (BMPs)
(Valentin-Opran 2002). A number have been discovered (growth
factors, platelet-rich plasma (PRP), and othermolecules) and their
use requires a delivery system that mimics the physical properties
and release kinetics of bone.
Some authors have proposed sinus augmentation without the use
of a graft material, coagulated blood acting as a scaffold for bone
formation. Lundgren proposed maintaining a space by suturing
the sinus lining to the lateral wall (Lundgren 2004). The implant
apex may be used to support the sinus membrane (Nedir 2006;
Hatano 2007; Thor 2007; Sohn 2008; Gabbert 2009; Pjetursson
2009). Some bone regeneration does occur as a result of this pro-
cedure though the actual clinical benefit remains in doubt since
this method has not been evaluated against appropriate control
procedures.
Alternative techniques to sinus lift
There are some alternative techniques to sinus augmentation,
which may be possible. Onlay bone grafts may be used for hor-
izontal or vertical augmentation. These procedures are evaluated
in another Cochrane systematic review (Esposito 2009).
Implants can also be placed with an angulated direction in order
to avoid the maxillary sinus (Aparicio 2001). These implants are
called ’tilted’ or ’angulated’ implants and they can only be used
when anatomical conditions permit.
Zygomatic implants offer an alternative to sinus augmentation.
Long implants pass through the sinus (Brånemark 2004) or later-
ally to the sinus into the zygomatic process. Zygomatic implants
are evaluated in anotherCochrane review (Esposito 2005). In some
situations angled implants may be placed into the pterygomaxilla
(Graves 1994).
Another alternative to sinus lift procedures is the use of short
implants. Current research is focused on evaluating short implants
placed without augmentation, offering the opportunity of a less
complex, cheaper and faster alternative to augmentation. There are
few comparative studies evaluating the efficacy of short implants
(Esposito 2009). There is some variation as to the definition of
short implants. Implants with lengths of 5 to 8 mm are currently
used, and may be defined as short implants (Renouard 2006),
though this is controversial as some authors consider implants of
7 to 10 mm to be short (das Neves 2006).
A review of longitudinal studies suggested a failure rate of approx-
imately 10% for implants 7 mm long (das Neves 2006). However
the design of the studies on which this estimate is based suggest
that this figure should be viewed with caution as it may represent
a gross underestimation. Nevertheless these figures suggest that
shorter implants may have a poorer prognosis than longer ones.
Since it is commonly believed that shorter implants (8 mm or
less) have a poorer prognosis than longer implants, clinicians place
longer implants if bone allows. When bone height is 5 to 8 mm
cliniciansmust decidewhether to augment or place short implants.
It is possible that in the future new and improved implant surface
modifications and designs, together with improved surgical tech-
niques may shift the balance in favour of short implants, when
the alternative is a more complex augmentation procedure. No
reliable evidence of the superiority of currently available surface
modifications or designs has been documented so far (Esposito
2007).
Several ’systematic’ reviews have been published on the outcome
of sinus lifting procedures (Tong 1998; Wallace 2003; Del Fabbro
2004; Emmerich 2005; Aghaloo 2007; Pjetursson 2008; Tan
2008;Nkenke 2009), however, since those findings were not based
on the most reliable clinical studies, a systematic review based
on the most reliable evidence would be useful to summarise the
current scientific knowledge.
O B J E C T I V E S
General objectives
To test the null hypothesis that there is no difference in the out-
comes of implant success, function, complication rate and patient
satisfaction as a result of bone augmentation, compared to no aug-
mentation. Furthermore there is no difference between different
maxillary sinus lift techniques for dental implant treatment with
regard to these outcomes.
Specific objectives
(A) To test whether and when sinus lift procedures are necessary.
(B) To test which is the most effective augmentation technique for
sinus lift.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled clinical trials (RCTs) including split-
mouth studies.
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Types of participants
Patients with missing teeth and an atrophic posterior maxilla who
may require augmentation of the maxillary sinus prior to or at
placement of dental implants.
Types of interventions
Any bone augmentation technique, active agent (such as bone
morphogenetic proteins, platelet-rich plasma) or biomaterials used
together with osseointegrated, root-formed dental implants. For
trials to be considered in this review, implants have to be placed
and the success/failure of the implant therapy has to be reported
at least at the endpoint of the abutment connection procedure.
The following time points were considered: abutment connection,
prosthetic loading, up to 1 year, 3 and 5 years after loading.
Types of outcome measures
Outcome measures included.
• Prosthesis failure: planned prosthesis which could not be
placed due to implant failure(s) and loss of the prosthesis
secondary to implant failure(s).
• Implant failure: implant mobility and removal of stable
implants dictated by progressive marginal bone loss or infection
(biological failures). Biological failures were grouped as early
(failure to establish osseointegration) and late failures (failure to
maintain the established osseointegration). Failures that occurred
before prosthesis placement were considered early failures.
Implant mobility could be assessed manually or with instruments
such as Periotest (Siemens AG, Benshein, Germany) or resonance
frequency (Osstell, Integration Diagnostics, Göteborg, Sweden).
• Augmentation procedure failure: failure of the
augmentation procedure not affecting the success of the implant.
• Major complications at treated sites (e.g. sinusitis,
infection, haemorrhage, etc.).
• Major complications at bone donor sites (e.g. nerve injury,
gait disturbance, infection, etc.).
• Patient satisfaction.
• Patient preference (only in split-mouth trials).
• Bone gain expressed in mm or percentage.
• Duration of the treatment time starting from the first
intervention to the functional loading of the implants.
• Treatment costs.
Trials evaluating only histological outcomes were not considered
in this review.
Search methods for identification of studies
For the identification of studies included or considered for this
review, detailed search strategies were developed for each database
searched. These were based on the search strategy developed for
MEDLINE (OVID) but revised appropriately for each database.
The search strategy used a combination of controlled vocabulary
and free text terms andwas runwith theCochraneHighly Sensitive
Search Strategy (CHSSS) for identifying randomised trials (RCTs)
in MEDLINE: sensitivity maximising version (2009 revision) as
referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the
Cochrane Handbook for Systematic Reviews of Interventions Version
5.0.2 (updated September 2009) (Higgins 2009). Details of the
MEDLINE search are provided in Appendix 1.
Searched databases
• The Cochrane Oral Health Group’s Trials Register (to 7th
January 2010), seeAppendix 2.
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2009, Issue 4), seeAppendix
3.
• MEDLINE via OVID (1950 to 7th January 2010),
seeAppendix 1.
• EMBASE via OVID (1980 to 7th January 2010),
seeAppendix 4.
The most recent electronic search was undertaken on 7th January
2010.
Language
There were no language restrictions.
Unpublished studies
We wrote to all the authors of the identified RCTs, we checked
the bibliographies of all identified RCTs and relevant review ar-
ticles, and we used personal contacts in an attempt to identify
unpublished or ongoing RCTs. In the first version of this review
we also wrote to more than 55 oral implant manufacturers and
we requested information on trials through an Internet discussion
group (implantology@yahoogroups.com), however we discontin-
ued this due to poor yield.
Handsearching
Details of the journals being handsearched by the Cochrane Oral
Health Group’s ongoing programme are given on the website:
http://www.ohg.cochrane.org/.
The following journals have been identified as being potentially
important to be handsearched for this review: British Journal of
Oral and Maxillofacial Surgery, Clinical Implant Dentistry and Re-
lated Research, Clinical Oral Implants Research, European Journal of
Oral Implantology, Implant Dentistry, International Journal of Oral
and Maxillofacial Implants, International Journal of Oral and Max-
illofacial Surgery, International Journal of Periodontics and Restora-
tive Dentistry, International Journal of Prosthodontics, Journal of
Clinical Periodontology, Journal of Dental Research, Journal of Oral
Implantology, Journal of Oral and Maxillofacial Surgery, Journal
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of Periodontology, and Journal of Prosthetic Dentistry. Where these
have not already been searched as part of the Cochrane Journal
Handsearching Programme, the journals were handsearched by
one review author up to the month in which the last electronic
search was undertaken.
Data collection and analysis
Study selection
The titles and abstracts (when available) of all reports identified
through the electronic searches were scanned independently by
two review authors. For studies appearing to meet the inclusion
criteria, or for which there were insufficient data in the title and
abstract to make a clear decision, the full report was obtained. The
full reports obtained from all the electronic and other methods
of searching were assessed independently by two review authors
to establish whether the studies met the inclusion criteria or not.
Disagreements were resolved by discussion. Where resolution was
not possible, a third review author was consulted. All studies meet-
ing the inclusion criteria then underwent validity assessment and
data extraction. Studies rejected at this or subsequent stages were
recorded in the table of excluded studies, and reasons for exclusion
recorded.
Data extraction
Data were extracted independently by two review authors using
specially designeddata extraction forms.The data extraction forms
were piloted on several papers and modified as required before
use. Any disagreement was discussed and a third review author
consulted where necessary. All authors were contacted for clarifi-
cation or missing information. Data were excluded until further
clarification was available if agreement could not be reached.
For each trial the following data were recorded.
• Year of publication, country of origin and source of study
funding.
• Details of the participants including demographic
characteristics, source of recruitment and criteria for inclusion.
• Details of the type of intervention.
• Details of the outcomes reported, including method of
assessment, and time intervals.
Risk of bias in included studies
An assessment of the risk of bias in included studies was under-
taken following the recommendations as described in Chapter 8
of the Cochrane Handbook for Systematic Reviews of Interventions
5.0.2 (Higgins 2009). Two review authors independently and in
duplicate assessed the risk of bias of all included studies. In the
case that the paper to be assessed had one or more review authors
in the authors list, it was independently evaluated only by those
review authors not involved in the trials. Any disagreement was
discussed and where necessary a third review author was consulted
to achieve consensus. Authors were contacted directly for clarifi-
cation.
A specific tool for assessing risk of bias in each included study was
adopted. This comprised a description and a judgement for each
entry in a risk of bias table, where each entry addressed a specific
feature of the study:
• Adequate sequence generation
• Allocation concealment
• Blinding (of outcome assessor)
• Incomplete outcome data addressed
• Free of selective reporting
• Free of other bias.
The judgement for each entry involved answering a question, with
answers ’Yes’ indicating low risk of bias, ’No’ indicating high risk
of bias, and ’Unclear’ indicating either lack of information or un-
certainty over the potential for bias.
After taking into account the additional information provided by
the authors of the trials, the overall risk of bias in included stud-
ies was assessed using three key domains: allocation concealment,
blinding of outcome assessor (where applicable) and completeness
of follow-up. Studies were graded into the following categories.
• Low risk of bias (plausible bias unlikely to seriously alter the
results) if all three key domains were met.
• High risk of bias (plausible bias that seriously weakens
confidence in the results) if one or more key domains were not
met.
Further quality assessment was carried out to assess sample size
calculations, definition of exclusion/inclusion criteria, and com-
parability of control and test groups at entry. The quality assess-
ment criteria were pilot tested using several articles.
Measure of treatment effect
For dichotomous outcomes, the estimate of effect of an interven-
tion was expressed as odds ratios (OR) together with 95% confi-
dence intervals (CIs). For continuous outcomes, mean differences
and standard deviations were used to summarise the data for each
group usingmean differences and 95%CIs. Appropriate data were
extracted from the split-mouth studies (Lesaffre 2009) and the
generic inverse variance method was used to enter these into Re-
view Manager (RevMan).
Unit of analysis issues
In parallel group studies the statistical unit was the patient and
not the augmentation procedure or the implants. In split-mouth
studies the augmentation procedures or the prostheses within each
pair were the unit of analysis (Lesaffre 2009).
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Dealing with missing data
All authors were contacted to retrieve missing data from authors
of trials. Methods for estimating missing standard deviations in
section 7.7.3 of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2009) were used.
Assessment of heterogeneity
The significance of any variations in the estimates of the treat-
ment effects from the different trials was to be assessed by means
of Cochran’s test for heterogeneity and heterogeneity would have
been considered significant if P < 0.1. The I2 statistic, which de-
scribes the percentage total variation across studies that is due to
heterogeneity rather than chance, will be used to quantify het-
erogeneity with I2 over 50% being considered moderate to high
heterogeneity.
Assessment of reporting biases
If there had been sufficient numbers of trials (more than 10) in
any meta-analysis, publication bias would have been assessed ac-
cording to the recommendations on testing for funnel plot asym-
metry (Egger 1997) as described in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2009). If asymmetry
were identified we would have examined possible causes.
Data synthesis
Meta-analysis was undertaken on where were studies of similar
comparisons reporting the same outcome measures. Odds ratios
were combined for dichotomous data, and mean differences for
continuous data, using random-effectsmodels provided there were
more than three studies in the meta-analysis. Data from split-
mouth studies were to be combined with data from parallel group
trials by themethod outlined by Elbourne (Elbourne 2002), using
the generic inverse variance method in RevMan.
Subgroup analysis and investigation of heterogeneity
Clinical heterogeneity was to be assessed by examining the types
of participants and interventions for all outcomes in each study. It
was decided not to formulate any hypotheses to be investigated for
subgroup analyses since no significant meta-analysis was expected.
However, this may be done in future updates of this review.
Sensitivity analyses
It was planned to undertake sensitivity analyses to examine the
effect of the study quality assessment on the overall estimates of
effect. In addition, the effect of including unpublished literature
on the review’s findings was also to be examined. There were too
few trials to undertake these analyses.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Characteristics of the trial setting and investigators
• Of the 29 potentially eligible trials (Froum 1998; Wannfors
2000; Tawil 2001; Hallman 2002; Barone 2005; Boyne 2005;
Kassolis 2005; Raghoebar 2005; Steigmann 2005; Szabó 2005;
Froum 2006; Suba 2006; Consolo 2007; Mangano 2007;
Aimetti 2008; Barone 2008; Cordaro 2008; Froum 2008;
Hallman 2008; Schaaf 2008; Bettega 2009; Cannizzaro 2009;
Choi 2009; Crespi 2009; Felice 2009a; Felice 2009b; Kim 2009;
Torres 2009; Triplett 2009), 19 had to be excluded for various
reasons such as: reported only histological outcomes without
presenting any implant related outcomes (Barone 2005; Kassolis
2005; Steigmann 2005; Froum 2006; Suba 2006; Consolo 2007;
Aimetti 2008; Cordaro 2008; Froum 2008; Hallman 2008; Choi
2009; Crespi 2009; Kim 2009); problems with study design and
data reporting (Froum 1998; Tawil 2001; Boyne 2005; Triplett
2009); too short follow-up (Barone 2008); presented data for
only 4 out of 16 treated patients (Aimetti 2008); and it was not a
randomised controlled trial (RCT) (Mangano 2007).
• Of the 10 included trials, three were conducted in Italy
(Cannizzaro 2009; Felice 2009a; Felice 2009b), two in Sweden
(Wannfors 2000; Hallman 2002), one in Spain (Torres 2009),
one in Germany (Schaaf 2008), one in France (Bettega 2009),
one in The Netherlands (Raghoebar 2005), and one was a
multicentre trial conducted in four European centres (Belgium,
Hungary, UK and Italy) (Szabó 2005).
• Two trials had a parallel group study design (Wannfors
2000; Cannizzaro 2009), six a split-mouth design (Hallman
2002; Raghoebar 2005; Szabó 2005; Bettega 2009; Felice 2009a;
Felice 2009b), and two a mixed split-mouth/parallel group
design (Schaaf 2008; Torres 2009) but only data from their split-
mouth portion could be used in the present review.
• For six trials it was declared that support was received from
industry directly involved in the product being tested also in the
form of free material (Wannfors 2000; Hallman 2002;
Raghoebar 2005; Szabó 2005; Felice 2009a; Felice 2009b) but
for one study (Felice 2009b) the discounted implants were not
under evaluation. The authors of four trials declared that no
support was received from commercial parties whose products
were being tested in the trials (Schaaf 2008; Bettega 2009;
Cannizzaro 2009; Torres 2009).
• Seven trials were conducted at university or specialist dental
clinics and three trials in private practices (Cannizzaro 2009;
Felice 2009a; Torres 2009). One of the centres (Bruges, Belgium)
of the multicentre trial (Szabó 2005) was also a private practice.
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Characteristics of the interventions
The following interventions were tested.
Is sinus lift necessary? (one trial with 15 patients)
• One to three 5 mm long implants of 6 mm in diameter
versus one to three 10 mm or longer implants of 4 mm in
diameter placed in sinuses augmented with 100% bovine
anorganic bone (Bio-Oss, Geistlich Pharmaceutical, Wolhusen,
Switzerland) with their lateral windows sealed with a resorbable
collagen membrane (OsseoGuard, Biomet 3i, Palm Beach, FL,
USA) 4 months prior to loading (Felice 2009a). All
augmentation procedures were performed under local
anaesthesia. All implants were left to heal submerged for 4
months. Rescue implants (MegaGen Implant Co. Lld.,
Gyeongbuk, South Korea) as short implants and EZ Plus
(MegaGen) as long implants, with internal connection, were
used. Implant site preparation was also different since a 5 mm
diameter trephine was used initially to prepare the osteotomy
sites for Rescue implants. Provisional screw-retained reinforced
resin prostheses were replaced after 4 months by definitive screw-
retained metal-ceramic prostheses.
Which is the most effective sinus lift procedure? (nine trials
with 235 patients)
• One-stage lateral sinus lift with monocortical iliac bone
blocks fixed usually with two implants left to heal for 6 months
versus two-stage lateral sinus lift with particulate bone from the
iliac crest left to heal for 6 months and then usually two implants
were inserted into the healed graft and left to heal for an
additional 6 months (Wannfors 2000). All the augmentation
procedures were performed under general anaesthesia. All
implants were turned titanium self tapping (Nobel Biocare,
Göteborg, Sweden) and were rehabilitated with screw-retained
cross-arch implant-supported prostheses.
• Two-stage lateral sinus lift with autogenous particulate bone
from the mandibular ramus versus two-stage lateral sinus lift
with a mixture of 80% of Bio-Oss and 20% of particulate bone
from the mandibular ramus, left to heal for 6 months in a split-
mouth trial (Hallman 2002). A fibrin glue (Tisseel Duo Quick,
Immuno, Wien, Austria) was added to the grafts after thrombin
(Thrombin, Immuno) for both interventions. A third treatment
group was composed of patients who refused to provide
autogenous bone but accepted the treatment with a two-stage
sinus lift with 100% Bio-Oss. For the latter group a resorbable
porcine-derived collagen barrier (Bio-Gide, Geistlich
Pharmaceutical) was used to cover the defect of sinus and the
healing time was prolonged to an average of 8.5 months (range:
8 to 9.5). Procedures were performed under local anaesthesia and
oral sedation. All implants were turned titanium self tapping
(Nobel Biocare, Göteborg, Sweden): Mark II implant type was
used in the former two groups and Mark III in the latter. All
patients were rehabilitated with screw-retained metal-ceramic
fixed prostheses.
• Two-stage lateral sinus lift with autogenous particulate bone
from the iliac crest versus two-stage sinus lift with 1.5 to 2 g
beta-tricalcium phosphate (Cerasorb, Curasan AG,
Kleinostheim, Germany) left to heal for 6 months (Szabó 2005).
In 10 of the 20 patients the alveolar crest was also widened with
cortical bone blocks fixed with microscrews. No membranes
were used to cover the bone. All the augmentation procedures
were performed under general anaesthesia. Patients were
instructed not to wear their upper dentures for 30 days. In 16
patients Ankylos (Degussa, Friadent, Germany) implants were
used, whereas in four patients Protetim (Hungary) implants were
used. The authors did not provide any explanation for using two
different implant systems. Two implants were placed in each
augmented sinus.
• One-stage sinus lift using one to three 8 mm long implants
placed in simultaneously crestally augmented sinus with
autogenous particulate bone, harvested from the implant site,
versus one to three 10 mm or longer implants placed in
simultaneously augmented sinuses using the lateral approach
with a mixture of 50% particulate autogenous bone from the
tuberosity area and 50% Bio-Oss (Cannizzaro 2009). A modified
’Cosci technique’ was used to crestally augment the sinus. In
brief implant sites were prepared with a 2.5 mm trephine drill up
to about 1 mm of the sinus cortical wall, to collect autogenous
bone, and with a 3.1 mm diameter atraumatic lifting drill.
Resorbable barriers (Biomend Extend, Sulzer Dental Inc.,
Carlsbad, CA, USA) were used to seal the lateral windows. All
augmentation procedures were performed under local
anaesthesia. All implants were left to heal submerged for 45 days
and were functionally loaded within 1 week after abutment
connection. All implants were tapered Screw-Vent MP-1 HA
Dual Transition Selective Surface implants (Zimmer Dental,
Carlsbad, CA, USA) inserted in underprepared osteotomy sites
with a torque of at least 35 N/cm.
• Two-stage sinus lift with lateral window approach using
either a synthetic resorbable barrier (Inion, GTR Biodegradable
Membrane System, Tampere, Finland) to keep the sinus
membrane or 100% granular Bio-Oss (Felice 2009b). Inion
barriers were used to seal the lateral windows. Inion barriers are
made of a synthetic co-polymer (trimethylene carbonate l-lactide
polyglycolide) that needs to be softened in a plasticising solution,
allowing the membrane to be cut and mould to fit exactly the
space. The barrier then hardens in the new position maintaining
the new shape and the space. This material should biodegrade in
situ after 8-12 weeks. All augmentation procedures were
performed under local anaesthesia. After 6 months, one to three
implants were placed per side and submerged for 4 months. All
implants were Way (Geass, Pozzuolo del Friuli (UD), Italy) with
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a laser treated surface and internal connection. Provisional screw-
retained reinforced resin prostheses were replaced after 4 months
by definitive screw-retained metal-ceramic prostheses.
Trials evaluating the efficacy of platelet-rich plasma (PRP)
with grafts (four trials with 114 patients)
• Two-stage lateral sinus lift with autogenous blocks and
particulate bone together with buccal onlays monocortico-
cancellous bone grafts, to reconstruct the width of the maxilla,
fixed with titanium screws harvested from the iliac crest with or
without PRP left to heal for 3 months in a split-mouth trial
(Raghoebar 2005). Barriers were not used. PRP was made using
the Platelet Concentration Collection System kit (PCCS kit, 3i
Implant Innovations Inc. Palm Beach Gardens, FL, USA). 54 ml
of blood were mixed with 6 ml of anticoagulant (citrate dextrose)
and processed with the platelet concentration system. To
promote the release of growth factors from the platelets, 10%
calcium chloride solution and the patient’s serum, as a source of
autologous thrombin, were added before actual reconstruction of
the defect with the bone graft. The resulting gel was mixed with
the bone graft and some gel was applied at the closure of the
wound at the side treated with PRP. Three implants were
inserted into the healed graft of each side and were left to heal for
additional 6 months. All the augmentation procedures were
performed under general anaesthesia. Surgical templates were
used to optimise implant insertion. All implants were turned
titanium self tapping (Nobel Biocare) and were rehabilitated
with two implant-supported prostheses.
• Two-stage sinus lift with lateral window approach using
either autogenous particulate bone from the iliac crest alone or
the same graft plus PRP (Schaaf 2008). All sites were also
horizontally augmented with corticospongeous blocks from the
iliac crest fixed with screws. PRP was produced at the university
Institutes of Clinical Immunology and Transfusion Medicine
under transfusion medical standards. Autologous platelet
concentrate from PRP derived from 450 ml CPD-anticoagulated
blood. The PRP was concentrated using differential
centrifugation, then stored for 24 h and adjusted up to 1010
platelets/ml. The concentrations obtained were 11 to 12 times
above the baseline level of whole blood. All augmentation
procedures were performed under general anaesthesia. After 4
months of healing, different implant systems (no details
provided) were inserted and left to heal submerged for 6 months.
• Two-stage lateral sinus lift with autogenous cortico-
cancellous blocks from the iliac crest versus granules of bone
with platelet concentrates (APCs) and a biologic glue (Tissucol,
Baxter SA, Maurepas, France), left to heal for 6 months in a
split-mouth trial (Bettega 2009). Plateletpheresis was made at
least 3 days before surgery on a plateletpheresis collection system
(Trima Accel, Version 5.1, Gambro BCT, Lakewood, CO), a
single-needle continuous-flow separation system. It was aimed to
obtain a post-donation platelet count of more than 100 x 106
per ml. Citrate (ACD-A) was used for anticoagulation. APCs
were delivered by the cell-processing laboratory in a 20 ml
transfer bag that was centrifuged for 15 minutes. The plasma was
removed with a plasma extraction device to reach the target
volume of 8 to 15 ml. 2 ml of cancellous bone was mixed with
half of the APCs volume and 1 ml of Tissucol. The remaining
APCs were mixed with 0.5 ml Tissucol to obtain a membrane for
covering the grafted area. Sites treated with bone blocks were
covered by 1 ml of Tissucol. Implants were placed 6 months after
the augmentation procedure.
• One trial compared one or two-stage sinus lift procedures
using a lateral window technique and 100% granular Bio-Oss
with or without PRP, left to heal for 6 months with a hybrid of
split-mouth parallel design trial (Torres 2009). Patients having
up to 4 mm of residual bone height were augmented first and
implant were placed after 6 months whereas patients with
residual bone more than 4 mm up to 7 mm received implants
during the sinus lift procedures. Implants were left to heal
unloaded for 6 months. 10 to 20 cc of venous blood were
collected 30 minutes prior to the surgery and mixed with a 3.8%
sodium citrate solution at a 5/1 ratio, achieving anticoagulation
through calcium binding. The blood was then centrifuged into
three and separated into three layers: red blood cells (RBCs),
PRP and poor plasma. Flow cytometry was used for platelet
counting. Platelets counts were 2.97 + 0.7-fold over peripheral
blood. PRP was activated with 30% CaCl2 solution and a PRP
gel was obtained and mixed with Bio-Oss. The entire bone of the
buccal window was removed, and, after the sinus was filled with
the bone substitute no barrier was used to seal the window.
Patients were instructed not to wear their upper dentures for 2 to
3 weeks after surgery. Osseotite (Biomet 3I, Palm Beach, FL,
USA) implants were used.
Characteristics of outcome measures
• Prosthesis failure: Wannfors 2000; Hallman 2002;
Raghoebar 2005; Szabó 2005; Cannizzaro 2009; Felice 2009a;
Felice 2009b; Torres 2009.
• Implant failure by individual implant stability assessment
with removed prostheses (with the exception for single implants):
Wannfors 2000; Hallman 2002; Raghoebar 2005; Szabó 2005;
Schaaf 2008; Bettega 2009; Cannizzaro 2009; Felice 2009a;
Felice 2009b; Torres 2009.
• Augmentation procedure failure: Wannfors 2000; Hallman
2002; Raghoebar 2005; Szabó 2005; Schaaf 2008; Bettega 2009;
Cannizzaro 2009; Felice 2009a; Felice 2009b; Torres 2009.
• Major complications at treated sites: perforation of the
sinus membrane only (though not a major complication):
Wannfors 2000; various complications: Hallman 2002;
Raghoebar 2005; Szabó 2005; Schaaf 2008; Bettega 2009;
Cannizzaro 2009; Felice 2009a; Felice 2009b; Torres 2009.
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• Major complications at bone donor site: Hallman 2002;
Raghoebar 2005; Szabó 2005; Cannizzaro 2009. In our analyses,
complications at treated and donor sites were combined when
appropriate.
• Patient satisfaction: no trial.
• Patient preference (only in split-mouth trials): Felice 2009a;
Felice 2009b. Data for one trial (Felice 2009a) were reported,
however they might be biased because of the study design. All
augmentation procedures were performed first and, after 4
months, test and control implants were placed bilaterally in the
same surgical session. The potential advantage of having the
prostheses on the short implants loaded 4 months earlier was lost
with this study design.
• Bone gain expressed in mm or percentage: vertical bone
gain was measured in mm by direct measurement in three trials
(Schaaf 2008; Bettega 2009; Felice 2009b), however for two
trials (Schaaf 2008; Bettega 2009) data were presented in a way
we could not use.
• Duration of the treatment period starting from the first
intervention to the functional loading of the implants: all trials.
• Treatment costs: no trials. However, this outcome measure
was indirectly extrapolated by us for all trials.
Duration of follow-up (including unpublished data
kindly provided by the investigators)
• To the abutment connection (Szabó 2005; Schaaf 2008;
Bettega 2009).
• Four-month post-loading (Felice 2009a; Felice 2009b).
• One-year post-loading (Hallman 2002; Cannizzaro 2009).
• Two-year post-loading (Raghoebar 2005; Torres 2009).
• Three-year post-loading (Wannfors 2000).
Risk of bias in included studies
The final quality scoring after having incorporated the additional
information kindly provided by the authors of the trials is sum-
marized in Additional Table 1. For each trial we assessed whether
it was at low or high risk of bias. Six studies were judged to be at
high risk of bias, and four at low risk of bias.
Allocation concealment
When assessing the information presented in the articles, alloca-
tion concealment was scored adequate for four trials (Cannizzaro
2009; Felice 2009a; Felice 2009b; Torres 2009) and unclear for all
others. When evaluating authors’ replies one trial was judged to
be properly concealed (Hallman 2002), one trial was judged not
to be properly concealed (Schaaf 2008) and four trials remained
unclear (Wannfors 2000; Raghoebar 2005; Szabó 2005; Bettega
2009).
Blinding
Blinding was not feasible in all of the included studies. Based
on evaluation of the trial reports, outcome assessment was scored
as blinded for three trials (Raghoebar 2005; Cannizzaro 2009;
Felice 2009b), not possible for one trial (Felice 2009a), though an
independent assessor was used, and unclear for the remaining six
trials. When evaluating authors’ replies, the outcome assessors of
two trials were judged to be blinded (Schaaf 2008; Torres 2009)
and not blinded for three trials (Wannfors 2000; Hallman 2002;
Szabó 2005). Blinding of outcome assessment for non-radiological
outcomes in Bettega 2009 is unclear.
Completeness of follow-up
When assessing the information presented in the articles, infor-
mation on drop outs was clearly presented in all trials with one
exception (Torres 2009) but the author supplied the missing in-
formation.
Inclusion/exclusion criteria
For more details see the Characteristics of included studies table.
Main inclusion criteria
• Severely resorbed maxillae (classes V-VI according to
Cawood 1991) with maxillary sinuses having < 5 mm in height
of residual alveolar bone with reduced stability and retention of
upper dentures (Raghoebar 2005).
• 1 to 5 mm in height of residual alveolar bone in the floor of
the edentulous sinus (Felice 2009b).
• 2 to 7 mm in height of residual alveolar bone in the floor of
the edentulous sinus (Wannfors 2000).
• 3 to 6 mm in height of residual alveolar bone in the floor of
the edentulous sinus (Cannizzaro 2009).
• 4 to 6 mm in height of residual alveolar bone in the floor of
the edentulous sinus (Felice 2009a).
• Less than 5 mm in height of residual alveolar bone in the
floor of the edentulous sinus (Hallman 2002; Szabó 2005).
• Less than 8 mm in height of residual alveolar bone in the
floor of the edentulous sinus (Bettega 2009).
• Severe atrophy of the edentulous or partially edentulous
posterior maxilla, and intention to treat with onlay bone blocks
and sinus floor augmentation (Schaaf 2008). Residual bone
height values appear to be in the range of 1 to 12 mm according
to the measurements kindly provided by the authors.
• 1 to 7 mm in height of residual alveolar bone in the floor of
the edentulous sinus (Torres 2009).
Main exclusion criteria
• Smokers (Bettega 2009).
• Bone metabolic diseases (Wannfors 2000).
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• Medication interfering with bone metabolism (i.e.
corticosteroids, bisphosphonate, etc.) (Wannfors 2000;
Cannizzaro 2009; Felice 2009a; Felice 2009b).
• Sinusitis (Wannfors 2000; Bettega 2009; Cannizzaro 2009;
Felice 2009a; Felice 2009b).
• History of maxillary sinusitis or sinus surgery (Bettega
2009; Torres 2009).
• History of reconstructive, pre-prosthetic surgery or previous
oral implantology (Raghoebar 2005).
• Edentulous period less than 1 year (Raghoebar 2005).
• Severe systemic disease (ASA III and IV) (Torres 2009).
• None specified (Hallman 2002; Szabó 2005).
Sample size
A priori calculation for the sample size was reported in only
two trials (Cannizzaro 2009; Felice 2009a); however in one trial
(Cannizzaro 2009) the number of included patients did not reach
the calculated sample size.
Baseline comparability between treatment groups
• No apparent major baseline differences (Wannfors 2000;
Raghoebar 2005; Felice 2009b; Torres 2009).
• Unclear whether major baseline differences existed
(Hallman 2002; Szabó 2005; Schaaf 2008; Bettega 2009).
• The following major baseline differences existed: more large
diameter implants were placed in the sites treated with 8 mm
long implants and crestal sinus lift (Cannizzaro 2009), and short
6 mm diameter implants were compared to longer implants with
a 4 mm diameter (Felice 2009a).
Effects of interventions
See: Summary of findings for the main comparison
Is sinus lift necessary? (one trial with 15 patients)
• One trial compared implants 5 mm long with 6 mm
diameter versus different implants at least 10 mm long with a
diameter of 4 mm, placed in laterally augmented sinus with
100% Bio-Oss (Felice 2009a). Only patients having 4 to 6 mm
of residual alveolar bone height with a thickness of 8 mm or
more below the sinus were included. Fifteen patients were treated
according to a split-mouth design. All patients were followed up
to 4 months after loading, therefore there were no drop outs.
One prosthesis could not be placed when planned in the short
implant side because one implant was found to be mobile at
abutment connection. This is not statistically significant
(McNemar P = 1.00, exact odds ratio (Stata ’epitab’ procedure) is
0 (95% confidence interval (CI) 0 to 39); unable to calculate
standard error (SE) to display data in RevMan). The implant was
successfully replaced by an implant placed more distally and
loaded. Four perforations of the sinus lining occurred: one in the
augmented group versus three in the 5 mm long implant group.
The difference was not statistically significant, McNemar P =
0.50, exact odds ratio (Stata) is 0 (95% CI 0 to 5.3) (unable to
calculate SE to display data in RevMan). All patients expressed
no preference for any of the two procedures, judging both of
them as acceptable however this measurement was considered to
be biased as previously described in the ’Characteristics of
outcome measures’. With respect to cost and treatment time, the
long implant group required one additional surgical intervention
for placing the implants (two-stage procedure) plus the cost of
the bone substitute with the barrier and 4 additional months to
complete the treatment. This trial was judged to be at low risk of
bias.
Which is the most effective sinus lift procedure? (nine
trials with 235 patients)
• One trial compared two techniques for augmenting
atrophic maxillary sinuses (Wannfors 2000) (Analysis 1.1). Only
patients having 2 to 7 mm of residual alveolar bone in the floor
of the edentulous sinus were included. Twenty patients were
treated with a one-stage sinus lift with monocortical iliac bone
blocks, and other 20 patients were treated with a two-stage sinus
lift with particulate bone from the iliac crest. All patients were
followed up to 3 years after loading; there were no drop outs.
However, data were presented in a way which could not be used
for all the time points we wanted to evaluate. Three patients
refused to have their prostheses removed and x-ray examination
at the 3-year follow-up. The only complications reported were
11 perforations of the sinus membrane in nine patients of the
one-stage group versus 11 perforations in 10 patients of the two-
stage group. At the time of abutment connection 11 implants in
eight patients were found to be not osseointegrated in the one-
stage group versus seven implants in six patients of the two-stage
group. At 1 year an additional five implants were lost in the one-
stage group versus one in the two-stage group. At 3 years one
additional implant was lost in the one-stage group versus two in
the two-stage group. Two patients of the one-stage group had
problems with the fixed prostheses at 1 year. In one patient the
prosthesis was lost due to four implant failures whereas in
another patient the prosthesis had to be redesigned due to lack of
space for the tongue (we did not consider this as a prosthesis
failure in the calculations, since it was independent of the bone
grafting technique). One prosthesis was lost due to the failure of
a strategically positioned implant at 1 year in the two-stage
group. There was no statistically significant difference between
the two treatment groups for any of the outcomes considered in
this review. With respect to cost and treatment time, all the
procedures were performed under general anaesthesia, however
the two-stage group required one additional surgical intervention
for placing the implants whereas implants were placed
concurrently with the augmentation procedure in the one-stage
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group. The healing period was 6 months longer in the two-stage
group. This trial was judged to be at high risk of bias.
• One trial compared three two-stage techniques for
augmenting atrophic maxillary sinuses (Hallman 2002) (Analysis
1.2). Only patients with less than 5 mm of alveolar bone height
in the sinus floor and fixed dentition on the opposite jaw were
included. The trial was designed as a sort of split-mouth/parallel
preference trial. Eleven patients willing to provide autogenous
bone from the mandibular ramus were treated with a split-
mouth approach (autogenous bone versus 80% Bio-Oss and
20% autogenous bone), whereas 10 patients who refused to have
their bone harvested from the mandible were treated with 100%
Bio-Oss. All patients were followed up to 1 year after loading;
there were no drop outs. During the post-operative phase no
complications occurred in either the augmented sites or the
donor sites. However a severe resorption of the autogenous bone
graft occurred in two patients. At abutment connection six
implants failed in five patients in the group treated with
autogenous bone only and two implants failed in two patients in
the group treated with 80% Bio-Oss. No implants or prostheses
were lost at the 1-year evaluation. The author informed us that
additional implants were lost at the 2-year follow-up in two
patients, causing the failure of the fixed prostheses. The complete
information should be published in a future 5-year follow-up
report. There was no statistically significant difference for any of
the outcomes considered in this review. With respect to cost and
treatment time, the only difference in cost was the use of the
bone substitute. The healing period was 6 months. The trial was
judged to be at high risk of bias.
• One trial compared two techniques for augmenting
atrophic maxillary sinuses (Szabó 2005) (Analysis 1.3). Only
patients with less than 5 mm of alveolar bone height in the sinus
floor were included. Twenty patients were treated with a split-
mouth approach with a two-stage sinus lift with particulate bone
from the iliac crest one side and with a two-stage sinus lift with
100% Cerasorb (a beta-tricalcium phosphate bone substitute) on
the contralateral sinus. In 10 patients an additional autogenous
onlay bone block was placed to widen the alveolar crest. All
patients were followed up to implant loading and there were no
drop outs. No serious post-operative complications occurred at
the implant sites. Three complications occurred at the bone graft
donor sites: one permanent sensory loss of the lateral femoral
cutaneous nerve and two had prolonged wound drainage (2 to 3
weeks). At abutment connection two implants failed, one in each
group, they both had to be replaced in order to place the
prosthesis and this caused a delay of 3 to 6 months (we did not
consider these as prosthesis failures in the calculations). There
was no statistically significant difference between the two
treatments for any of the outcomes considered in this review.
With respect to cost and treatment time, the only difference was
the cost of the bone substitute. The trial was judged to be at high
risk of bias.
• One trial compared two one-stage techniques for
augmenting maxillary sinuses (Cannizzaro 2009) (Analysis 1.4).
Only patients having 3 to 6 mm bone height at the sinus floor
were included. Twenty patients were treated with a sinus lift
through a crestal approach and autogenous bone and 8 mm long
implants, and 20 patients were treated with a sinus lift through a
lateral window approach with a mixture of 50% particulate
autogenous bone from the tuberosity area and 50% Bio-Oss and
implants at least 10 mm long. All patients were followed up to 1
year after loading, and there were no drop outs. Four
complications occurred in four sinuses laterally augmented - one
abscess and one sinusitis, both determining the failure of the
graft and the implants, versus one peri-implant infection in the
short implant group. One implant failed in the short implant
group at abutment connection and five implants (four in the
immediate post-operative phase and one at abutment
connection) in three patients in the long implant group. Two
prostheses could not be placed in the long implant group versus
one in the short implant group because of implant failures.
There was no statistically significant difference for any of the
outcomes considered in this review. There was an additional cost
of the bone substitute in the group with the lateral approach. All
implants were loaded 7 weeks after sinus lift. The trial was
judged to be at low risk of bias.
• One trial compared two two-stage techniques for
augmenting maxillary sinuses using a lateral window approach
(Felice 2009b) (Analysis 1.5; Analysis 1.6). Only patients having
1 to 5 mm bilateral bone height at the sinus floor were included.
Ten patients were treated with a split-mouth approach. After
elevation of the sinus lining, one side was filled with granular
Bio-Oss whereas in the contra-lateral site, an Inion resorbable
rigid barrier was used to maintain space to allow bone
regeneration. All patients were followed up to 4 months after
loading, and there were no drop outs. After 6 months, both
interventions gained a statistically significant amount of bone
(14.4 mm for Inion versus 14.1 mm for Bio-Oss) but there was
no statistically significant difference between the procedures.
There were no differences in complications between groups (two
perforations of the maxillary lining at the Inion treated sites
versus one at Bio-Oss site, Analysis 1.5), however, in one of the
patients where a perforation occurred at the Inion site, at
implant placement, the sinus was two thirds filled with soft
tissue. Implants were placed anyway and the site was successfully
retreated with Bio-Oss. No implant failed. The clinician
preferred Bio-Oss because it was simpler to handle. There were
no statistically significant differences in patient preference for
either of the two techniques 1 month after surgery and 1 month
after delivery of definitive prostheses: eight patients had no
preference while two preferred the Bio-Oss treated side. With
respect to cost, both procedures used Inion barriers, but only one
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procedure used the Bio-Oss. There was no difference in time
taken to complete the augmentation procedure (19.8 minutes for
Inion versus 20.5 for Bio-Oss) and all implants were loaded 11
months after sinus lift. The trial was judged to be at low risk of
bias.
Trials evaluating the efficacy of platelet-rich plasma (PRP)
with grafts (four trials with 114 patients)
• One trial compared two techniques for augmenting
resorbed maxillae including atrophic maxillary sinuses
(Raghoebar 2005) (Analysis 1.7). Only patients with less than 5
mm of alveolar bone height in the sinus floor were included. Five
patients were treated with a split-mouth approach with two-stage
sinus lift with autogenous bone together with buccal onlay grafts,
harvested from the iliac crest, one side with PRP and the other
without. All patients were followed for 2 years after implant
loading and there were no drop outs. No serious complications
occurred at the grafted sites: one sinus membrane was perforated
during surgery but healing was uneventful. A small incision
breakdown occurred in the first week at the non-PRP side of one
patient. A seroma which healed uneventfully was the only
complication that occurred at the donor sites. During the
prosthetic phase one implant failed in the PRP side, but no
prosthesis failed. There was no statistically significant difference
between the two techniques for any of the outcomes considered
in this review. The difference in cost and treatment time was the
use of PRP. Prostheses were inserted about 10 months after
augmentation. The trial was judged to be at high risk of bias.
• One trial compared two-stage sinus lift with lateral window
approach using either autogenous particulate bone from the iliac
crest alone or the same graft with PRP in fully edentulous
patients (Schaaf 2008) (Analysis 1.7). All sites were also
horizontally augmented with corticospongeous blocks and left to
heal for 4 months. There were two publications for this trial.
The first publication included 34 patients treated according to a
split-mouth design and 19 patients treated according to parallel
group design but no clinical data were provided. In the second
publication only the clinical data of the 34 patients treated with
a split-mouth approach were presented and only these data are
presented in this review. All patients were followed up to
abutment connection (6 months after implant insertion) and
there were no drop outs. Only complications at augmented sites
were reported: one sinusitis in two patients, one from each
group. Six patients experienced implant failures at abutment
connection: one patient lost one implant at both sites, three
patients lost one implant each at the non-PRP treated sites only,
and two patients lost one and three implants at the PRP side.
There was no statistically significant difference between the two
techniques for any of the outcomes considered in this review.
The difference in cost and treatment time was the use of PRP.
The trial was judged to be at high risk of bias.
• One trial compared two two-stage techniques for
augmenting maxillary sinuses (Bettega 2009) (data not shown).
Only patients with less than 8 mm of alveolar bone height in the
sinus floor were included. Eighteen patients were treated with a
split-mouth approach with two-stage sinus lift with autogenous
bone blocks from the iliac crest and Tissucol on one side and
autologous granular bone and autologous platelet concentrate
(APC) with Tissucol on the other. Patients were followed for 1
year after implant placement and there were two drop outs
before implant placement for financial reasons. There was no
complication due to cytapheresis or surgery. All implants were
stable 1 year after placement. There was no statistically
significant difference between the two techniques for any of the
outcomes considered in this review. The difference in cost and
treatment time was the use of APCs. The trial was judged to be
at high risk of bias.
• One trial compared one or two-stage sinus lift procedures
using a lateral window technique and 100% granular Bio-Oss
with or without PRP, left to heal for 6 months with a hybrid of
split-mouth/parallel design trial (Torres 2009). In the original
publication there were 87 patients included but only the data
from the 57 patients treated according to a split-mouth
procedure are presented here (Analysis 1.7). Twenty-five patients
having up to 4 mm of residual bone height were augmented first
and 98 implants were placed after 6 months whereas in 32
patients with residual bone ranging between 4 mm to 7 mm 128
implants were placed simultaneously to the sinus augmentation
procedure. Implants were left to heal unloaded for 6 months. All
patients were followed for 2 years after loading and there were no
drop outs. Five perforations of the maxillary membrane occurred
in five patients: three patients belonged to the PRP group and
two to the non-PRP group. Partial loss of the graft occurred in
five patients treated with the two-stage procedure: two patients
belonged to the PRP group and three to the non-PRP group.
According to the authors no prosthesis failed. Four implants
failed in three patients treated according a two-stage procedure.
Three implants failed in two patients at sides which were not
treated with PRP. There was no statistically significant difference
between the group receiving PRP and the group that did not
receive PRP for any of the outcomes considered in this review.
The difference in cost and treatment time was the use of PRP.
The trial was judged to be at low risk of bias.
Meta-analysis was only possible for the three trials which com-
pared, in split-mouth trials, particulate bone from the iliac crest
(Raghoebar 2005; Schaaf 2008) or Bio-Oss (Torres 2009) with
and without PRP. In two studies (Raghoebar 2005; Schaaf 2008),
sites were also augmented with onlay blocks of autogenous bone.
There were no statistically significant differences between groups
who received PRP and those who did not for implant failures and
complications (Figure 1).
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Figure 1. Forest plot of comparison: 1 Different sinus lift procedures, outcome: 1.7 Autogenous bone or
Bio-Oss +/- PRP.
D I S C U S S I O N
Twenty-nine potentially eligible trials were identified, but only 10
met our inclusion criteria. Twelve trials had to be excluded because
presented only histological data. The observation that themajority
of randomised clinical trials evaluating sinus lift procedures report
only histological findings without providing any useful informa-
tion on the actual clinical outcome of the sinus lift procedure and
implant rehabilitation, is both disappointing and alarming. This
is not to say that histological information is not useful, but if not
backed up by meaningful clinical outcomes it appears that hu-
man beings are used instead of animal as histological experimental
models and this is difficult to justify.
Sample sizes were relatively small with only two trials (Cannizzaro
2009; Felice 2009a) reporting a sample size calculation. It is there-
fore possible that many of these trials were underpowered to
demonstrate any significant difference between groups. Neverthe-
less the included trials did provide limited but indeeduseful insight
into possible avenues for future clinical research and some clinical
indications which should be carefully evaluated by clinicians when
deciding whether to perform an augmentation procedure or not,
or which augmentation procedure to select.
We first evaluated whether and when it may be necessary to aug-
ment maxillary sinus and then which are the most effective aug-
mentation procedures. This distinction is relevant since it is pos-
sible that ineffective procedures which could be even potentially
dangerous are widely performed, despite no improvements of
treatment prognosis or patients’ quality of life.
Only one trial evaluatedwhether sinus lift procedures are indicated
in patients having a residual crestal height between 4 to 6 mm (
Felice 2009a). The findings of this study are inconclusive due to the
small sample size and the short follow-up (4months after loading),
however, they suggest that 5 mm long implants with a diameter
of 6 mm can be successfully loaded 4 months after placement
without the need of any augmentationprocedure. Though the only
implant failure occurred in the short implant group, the implant
was successfully replaced with another short implant placed more
distally. There is the need for more trials to understand in which
clinical situations sinus lift procedures are beneficial for patients.
When evaluating which are the most effective augmentation pro-
cedures we have eight trials providing some indications (Wannfors
2000; Hallman 2002; Raghoebar 2005; Szabó 2005; Schaaf 2008;
Bettega 2009; Cannizzaro 2009; Felice 2009b). Studies can be
grouped in the following way.
When trying to answer the question whether grafting is necessary
to obtain bone regeneration, even in case of severely atrophic sinus,
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the findings from the only pilot trial investigating this hypothesis
(Felice 2009b) clearly indicated that a graft is not needed to obtain
new bone in the sinus cavity, if it is possible to keep sufficient space
using a resorbable rigid barrier. On the other hand, the operator
found that it was technically simpler to use a bone substitute rather
than to mould a space-maintaining barrier. The same study also
suggested that there is not a clear correlation between the amount
of newly formed bone, evaluated with histomorphometry, and the
clinical success of the implants. In fact, all implants became suc-
cessfully osseointegrated also in presence of an average of 24% of
newly formed bone. In general, using surrogate outcomes, such
as histomorphometry, as the only outcome on which to predict
implant success in case of sinus augmentations with various mate-
rials, is shown to be inaccurate and misleading. Clinically relevant
primary outcomes such as implant failure and complication rates
should be used in conjunction with surrogate outcomes.
The question whether autogenous bone could be replaced by bone
substitutes to reduce patient morbidity was addressed in two trials
(Hallman 2002; Szabó 2005). One trial (Szabó 2005) is of little
use because the follow-upwas limited to abutment connection and
onlay bone blocks were used in half of the patients. The findings of
other trial (Hallman 2002) suggest that 80% to 100% of Bio-Oss
can be used as bone substitute. Autogenous bone grafting might
be replaced by bone substitutes for this indication, however larger
trials with longer follow-up should be conducted to validate these
preliminary findings.
One trial compared a one-stage crestal sinus lift procedure with
autogenous bone and 8 mm long implants with a lateral window
sinus lift with a mix of autogenous bone and 50% Bio-Oss to
place longer implants (Cannizzaro 2009). Though no statistically
significant differences were found, there were more complications
and failures with the lateral window augmentation procedure. It is
interesting to observe that all implants were placed in bone with a
residual height of 3 to 6 mm and were loaded less than 2 months
after sinus lift. It is generally accepted that 2 months in humans is
insufficient time to allow for new bone formation. Therefore the
original bone must have been sufficient to hold the implants, with
both lifting procedures adding little or no benefit.
When comparing a one-stage monocortical bone block versus a
two-stage technique with particulate bone harvested from the iliac
crest for maxillary sinus lifting, no statistically or clinically signif-
icant differences were observed (Wannfors 2000). However, the
use of autogenous bone blocks from the iliac crest in a one-stage
procedure is a technique seldom used nowadays and most of the
sinus lifting procedures are now performed under local anaesthe-
sia.
Four trials (Raghoebar 2005; Schaaf 2008; Bettega 2009; Torres
2009) evaluated the possible advantage of using platelet-rich
plasma (PRP) to speed bone healing for sinus augmentation. There
is no evidence of a clinical benefit from the use of PRP, therefore
there appears to be no reasons to justify its use in this application.
Most of the augmentation procedures evaluated in these trials were
performed by experienced clinicians, therefore caution is recom-
mended when extrapolating the results of the present review to
other clinical settings, such as general practice. Clinicians should
carefully evaluate the potential added benefits for each individual
patient of maxillary sinus augmentation. Where a benefit is antic-
ipated the more effective procedure associated with fewer risks of
complication/discomfort for the patient should be selected.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Conclusions are based on 10 small trials including 250 patients,
sometimes with short follow-up, and generally assessed as being at
high risk of bias. Therefore these results should be interpreted with
great caution and should be viewed as very preliminary, requiring
confirmation by large multicentre trials.
• One trial investigated whether and when it is necessary to
augment maxillary sinus.
(1) It is still unclear when sinus lift procedures are needed.
(2) Implants 5mm long and 6mmwide can be successfully loaded
in maxillary bone with a residual height of 4 to 6 mm below the
sinus without making any augmentation procedure, though the
long-term prognosis is unclear.
• Nine trials investigated which are the most effective sinus
lift techniques, four of which evaluated the efficacy of platelet-
rich plasma (PRP).
(1) If the residual alveolar bone height is 3 to 6 mm, a crestal ap-
proach to lift the sinus lining and place 8 mm implants may pos-
sibly lead to fewer complications than a lateral window approach
to place implants at least 10 mm long.
(2) Keeping the sinus lining elevated bymeans of a rigid resorbable
barrier in presence of 1 to 5 mm of residual bone height without
the addition of a graft is sufficient to regenerate new bone to allow
rehabilitation with implant-supported prostheses. However, it is
technically simpler to fill the sinus with a granular bone substitute.
(3) Bone substitutes such Bio-Oss and Cerasorb appear to be as
effective as autogenous bone grafts for augmenting atrophic max-
illary sinuses, therefore they could be used as a replacement for
autogenous bone grafting.
(4) There is no evidence that the addition of PRP treatment to
autogenous bone grafts or bone substitutes improves the outcome
of sinus lift procedures for implant rehabilitation.
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Implications for research
In order to understand when sinus lift procedures are needed and
which are the most effective sinus lift techniques, larger, well de-
signed trials are needed. Such trials should include long-term fol-
low-up and be reported according to the Consolidated Standards
of ReportingTrials (CONSORT) guidelines (Moher 2001) (http:/
/www.consort-statement.org/). It is difficult to provide clear in-
dications with respect of which sinus lift procedures should be
evaluated first, however, once established in which clinical situa-
tions these procedures are actually needed, priority should be given
to those interventions that are simpler, less invasive, involve less
risk of complications, and reach their goals within the shortest
timeframe. Research efforts should be concentrated on a few im-
portant clinical questions, using larger sample sizes. This might
be obtained through collaborative efforts among various research
groups. Among of the identified research priorities is to evaluate
whether and when one-stage lifting via a crestal approach can re-
place the more invasive lateral window procedures and whether
bone substitutes can be used for replacing autogenous bone in
augmenting severely atrophic maxillary sinuses.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bettega 2009
Methods Randomised, split-mouth study, 1-year post-implant placement follow-up. Two with-
drawals for financial reasons
Participants Patients having less than 8 mm of alveolar bone at the floor of the sinus. Adults treated
at the Plastic and Maxillofacial Surgery Unit, Grenoble, France. Exclusion criteria were
smokers, maxillary sinus lesion or history of sinusitis or sinus surgery, abnormal blood
counts, ASA score 2 or more. 18 patients were treated
Interventions Two-stage sinus lift with autogenous cortico-cancellous blocks from the iliac crest versus
granules of bone with platelet concentrates (APCs) and a biologic glue (Tissucol, Baxter
SA,Maurepas, France) left to heal for 6months in a split-mouth trial. Plateletpheresis was
made at least 3 days before surgery on a plateletpheresis collection system (Trima Accel,
Version 5.1, Gambro BCT, Lakewood, CO), a single-needle continuous-flow separation
system. It was aimed to obtain a post-donation platelet count of more than 100 x 106
per ml. Citrate (ACD-A) was used for anticoagulation. APCs were delivered by the cell-
processing laboratory in a 20 ml transfer bag that was centrifuged for 15 minutes. The
plasma was removed with a plasma extraction device to reach the target volume of 8 to
15 ml. 2 ml of cancellous bone was mixed with half of the APCs volume and 1 ml of
Tissucol. The remaining APCs were mixed with 0.5 ml Tissucol to obtain a membrane
for covering the grafted area. Sites treated with the bone block were covered by 1 ml of
Tissucol. Implants were placed 6 months after the augmentation procedure
Outcomes Implant failure. Complications at the augmented and donor sites. Histomorphometrical
and radiographic evaluation: sinus floor height and bone density on panoramic radio-
graphs and CT scans
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: “(Randomization) was chosen
through a two-element randomization ta-
ble”
Allocation concealment? Unclear Article: “The iliac crest graft was then har-
vested, and the destination for the two tech-
niques (traditional versus APC) was chosen
through a two-element randomization ta-
ble”
Author did not reply to our request for clar-
ification.
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Bettega 2009 (Continued)
Blinding?
All outcomes
Unclear Article: “All radiological images were read
blindly by a radiologist”. However it was
not specified if the other outcomemeasures
were assessed blindly
Author did not reply to our request for clar-
ification.
Incomplete outcome data addressed?
All outcomes
No Data partially presented.
Author did not reply to our request for clar-
ification.
Free of selective reporting? Yes All outcomes reported were previously de-
scribed in the published research protocol
Free of other bias? Yes
Cannizzaro 2009
Methods Randomised trial of parallel groupdesign, 1-year post-loading follow-up.Nowithdrawals
Participants Patients having 3 to 6 mm of alveolar bone at the floor of the sinus. Adults treated at
a private dental practice, Pavia, Italy. Exclusion criteria were: general contraindications
to implant surgery, subjected to irradiation in the head and neck area less than 1 year
ago, treated or under treatment with intravenous amino-bisphosphonates, poor oral
hygiene and motivation, uncontrolled diabetes, pregnant or lactating, substance abusers,
psychiatric problems or unrealistic expectations, lack of opposite occluding dentition/
prosthesis in the area intended for implant placement, acute infection in the area intended
for implant placement. 20 patients were treated in each group
Interventions One-stage sinus lift using one to three 8 mm long implants placed in simultaneously
crestally augmented sinus with autogenous particulate bone, harvested from the implant
site, versus one to three 10 mm or longer implants placed in simultaneously augmented
sinuses using the lateral approach with a mixture of 50% particulate autogenous bone
from the tuberosity area and 50% Bio-Oss. A modified ’Cosci technique’ was used to
crestally augment the sinus. In brief implant sites were prepared with a 2.5 mm trephine
drill up to about 1 mm of the sinus cortical wall, to collect autogenous bone, and
with a 3.1 mm diameter atraumatic lifting drill. Resorbable barriers (Biomend Extend,
Sulzer Dental Inc., Carlsbad, CA, USA) were used to seal the lateral windows. All the
augmentation procedures were performed under local anaesthesia. All implants were left
to heal submerged for 45 days and were functionally loaded within 1week after abutment
connection. All implants were tapered Screw-Vent MP-1 HA Dual Transition Selective
Surface implants (Zimmer Dental, Carlsbad, CA, USA) inserted in under prepared
osteotomy sites with a torque of at least 35 N/cm
Outcomes Prosthesis and implant failure. Complications at the augmented and donor sites. Peri-
implant marginal bone levels
Notes
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Cannizzaro 2009 (Continued)
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: “A computer generated restricted
randomisation list was created”
Allocation concealment? Yes Article: “Only one of the investigators
(Marco Esposito), not involved in the se-
lection and treatment of the patients, was
aware of the randomization sequence and
could have access to the randomization list
stored in his pass-word protected portable
computer. The randomized codes were en-
closed in sequentially numbered, identical,
opaque, sealed envelopes. Envelopes were
opened sequentially after eligible patients
were anaesthetised, therefore, treatment al-
location was concealed to the investigators
in charge of enrolling and treating the pa-
tients”
Blinding?
All outcomes
Yes Article: “One dentist (Giuseppe Fontana)
not involved in the treatment of the pa-
tients made all the clinical assessments
without knowing group allocation, there-
fore outcome assessor was blinded, how-
ever Bio-Oss augmented sites could be
identified on radiographs because they ap-
peared more radio-opaque and implants
were longer”
Incomplete outcome data addressed?
All outcomes
Yes All data presented, no drop outs.
Free of selective reporting? Yes All planned outcomes were reported.
Free of other bias? Unclear The 8 mm implants were in general of
larger diameter than the longer implants,
therefore it cannot be ruled out that also
the implant diameter played a role in the
clinical outcome
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Felice 2009a
Methods Randomised trial of split-mouth design, 4-month post-loading follow-up. No with-
drawals
Participants Patients having 4 to 6 mm of alveolar bone at the floor of the sinus. Adults treated in
dental hospitals/university clinics in Bologna, Roma and Chieti, Italy. Exclusion criteria
were: general contraindications to implant surgery, patients irradiated in the head and
neck area, immunosuppressed or immunocompromised patients, patients who took or
are taking bisphosphonates intravenously, patients with periodontitis, poor oral hygiene
and motivation, uncontrolled diabetes, pregnancy or lactation, addiction to alcohol or
drugs, psychiatric problems, lack of opposite occluding dentition in the area intended
for implant placement, patients with an acute or chronic infection inflammation in the
area intended for implant placement. 15 patients were treated
Interventions One to three 5 mm long implants of 6 mm in diameter versus one to three 10 mm or
longer implants of 4 mm in diameter placed in sinuses augmented with 100% bovine
anorganic bone (Bio-Oss, Geistlich Pharmaceutical, Wolhusen, Switzerland) with their
lateral windows sealed with a resorbable collagen membrane (OsseoGuard, Biomet 3i,
Palm Beach, FL, USA) 4 months before. All augmentation procedures were performed
under local anaesthesia. All implants were left to left to heal submerged for 4 months.
Rescue implants (MegaGen Implant Co. Lld., Gyeongbuk, South Korea) as short im-
plants and EZ Plus (MegaGen) as long implants, all with internal connection were used.
Implant site preparation was also different since a 5 mm diameter trephine was used
initially to prepare the osteotomy sites for Rescue implants. Provisional screw-retained
reinforced resin prostheses were replaced after 4 months by definitive screw-retained
metal-ceramic prostheses
Outcomes Prosthesis and implant failure. Complications at the treated sites. Peri-implant marginal
bone levels and patient preference
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: “A computer generated restricted
randomisation list was created”
Allocation concealment? Yes Article: “Only one of the investigators
(ME), not involved in the selection and
treatment of the patients, was aware of the
randomisation sequence and could have
access to the randomisation list stored
in his pass-word protected portable com-
puter. The randomised codes were en-
closed in sequentially numbered, identical,
opaque, sealed envelopes. Envelopes indi-
cating which site to augment were opened
sequentially just prior to the augmentation
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Felice 2009a (Continued)
procedure. Therefore, treatment allocation
was concealed to the investigators in charge
of enrolling and treating the patients”
Blinding?
All outcomes
Yes Article: “One dentist (GP) not involved in
the treatment of the patients performed all
clinical and radiographic assessments with-
out knowing group allocation, therefore
the outcome assessor was blinded, however
the Bio-Oss augmented sites could be iden-
tified both clinical when testing implant
stability because of the different diameters
and on radiographs because they appeared
more radio-opaque and implants were dif-
ferent”
Incomplete outcome data addressed?
All outcomes
Yes All data presented, no drop outs.
Free of selective reporting? Yes All planned outcomes were reported.
Free of other bias? No Implants of small diameter (4 mm) and of
different design were inserted with a dif-
ferent surgical technique in the augmented
group instead of the originally planned
identical but longer implants
Patients had always the augmentation pro-
cedure performed first and then had im-
plant placement bilaterally. This may have
affected patient preference since patient
could not experience the benefit of having
the prosthesis 4 months earlier
Felice 2009b
Methods Randomised trial of split-mouth design, 5-month post-loading follow-up. No with-
drawals
Participants Patients having 1 to 4 mm of alveolar bone at the floor of the sinus. Adults treated in
dental hospitals/university clinics in Bologna, Roma and Chieti, Italy. Exclusion criteria
were: general contraindications to implant surgery, patients irradiated in the head and
neck area, immunosuppressed or immunocompromised patients, patients who took or
are taking bisphosphonates intravenously, patients with periodontitis, poor oral hygiene
and motivation, uncontrolled diabetes, pregnancy or lactation, addiction to alcohol or
drugs, psychiatric problems, lack of opposite occluding dentition in the area intended
for implant placement, patients with an acute or chronic infection inflammation in the
area intended for implant placement. 10 patients were treated
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Felice 2009b (Continued)
Interventions Two-stage sinus lift with lateral window approach using either a synthetic resorbable
barrier (Inion, GTR Biodegradable Membrane System, Tampere, Finland) to keep the
sinus membrane or 100% granular Bio-Oss. Inion barriers were used to seal the lateral
windows. Inion barriers are made of a synthetic co-polymer (trimethylene carbonate l-
lactide polyglycolide) that needs to be softened in a plasticising solution, allowing the
membrane to be cut andmould to fit exactly the space. The barrier then harden in the new
positionmaintaining the new shape and the space. Thismaterial should biodegrade in situ
after 8-12 weeks. All augmentation procedures were performed under local anaesthesia.
After 6 months, one to three implants were placed per side and submerged for 4 months.
All implants were Way (Geass, Pozzuolo del Friuli (UD), Italy) with a laser treated
surface and internal connection. Provisional screw-retained reinforced resin prostheses
were replaced after 4 months by definitive screw-retained metal-ceramic prostheses
Outcomes Prosthesis and implant failure. Complications at the treated sites. Amount of vertically
augmented bone (mm). Peri-implant marginal bone levels, patient and clinician prefer-
ence. Time necessary to complete the augmentation procedure
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: “A computer generated restricted
randomisation list was created”
Allocation concealment? Yes Article: “Only one of the investigators
(Marco Esposito), not involved in the se-
lection and treatment of the patients, was
aware of the randomization sequence and
could have access to the randomization list
stored in his pass-word protected portable
computer. The randomized codes were en-
closed in sequentially numbered, identical,
opaque, sealed envelopes. Envelopes were
opened sequentially after the sinus lining
epithelium of site number 1 was lifted,
therefore, treatment allocation was con-
cealed to the investigators in charge of en-
rolling and treating the patients”
Blinding?
All outcomes
Yes Article: “One dentist (Gerardo Pellegrino)
, not involved in the treatment of the pa-
tients, made all the clinical assessments
without knowing group allocation, there-
fore outcome assessorwas blinded, however
Bio-Oss augmented sites could be identi-
fied on radiographs because they appeared
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Felice 2009b (Continued)
more radio-opaquewhile Inion treated sites
appeared rather radiolucent”
Incomplete outcome data addressed?
All outcomes
Yes All data presented, no drop outs.
Free of selective reporting? Yes All planned outcomes were reported.
Free of other bias? Yes
Hallman 2002
Methods Randomised, split-mouth study, 1-year post-loading follow-up. No withdrawals
Participants Patients having less than 5 mm of alveolar bone in the floor of the sinus. Adults treated at
the Gävla Hospital, Gävla, Sweden. No specific exclusion criteria were given (unhealthy,
systemic or local contraindications such as undergoing radiation therapy). 11 patients
were treated in the split-mouth study and 10 in the preference group
Interventions Two-stage sinus lift with autogenous particulate bone from the mandibular ramus versus
two-stage sinus lift with a mixture of 80% of bovine anorganic bone (Bio-Oss) and 20%
of particulate bone from the mandibular ramus left to heal for 6 months. A fibrin glue
(Tisseel Duo Quick, Immuno, Wien, Austria) was added to the grafts after thrombin
(Thrombin, Immuno). A third group was composed by patients who refused to provide
autogenous bone but accepted the treatment with a two-stage sinus lift with 100%
Bio-Oss. For the latter group a resorbable porcine-derived collagen barrier (Bio-Gide,
Geistlich Pharmaceutical) was used to cover the defect of sinus, and the healing time
was prolonged to an average of 8.5 months (range: 8 to 9.5). Procedures were performed
under local anaesthesia and oral sedation. All implants were turned titanium self tapping
(Nobel Biocare, Göteborg, Sweden): Mark II type implants were used in the former two
groups and Mark III in the latter. All patients were rehabilitated with screw-retained
metal-ceramic fixed prostheses
Outcomes Prosthesis and implant failure. Complications at the augmented and donor sites. Histo-
morphometrical evaluation
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: No information presented.
Author’s reply: “The randomization was
done by a third party as a lottery. In an en-
velope there were 12 papers with either 6
possibilities for themixture to be on the left
side or the right side. Each patient was al-
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Hallman 2002 (Continued)
lotted by picking up one paper which said
mixture on the left or right side”
Allocation concealment? Yes Article: No information presented.
Author’s reply: “The surgeon knew the out-
come of the surgery at the time of surgery
just before making the incision”
Blinding?
All outcomes
No Article: No information presented.
Author’s reply: “The study was not
blinded”.
Incomplete outcome data addressed?
All outcomes
Yes All data presented, no drop outs.
Free of selective reporting? Yes
Free of other bias? Unclear The study was supported by the producer
of the bone substitute
Raghoebar 2005
Methods Randomised, split-mouth study, 2-year post-loading follow-up. No withdrawals
Participants Patients with severely resorbed maxilla and reduced stability and retention of the upper
denture. Adults treated at the University Hospital Groningen, The Netherlands. Patients
were excluded if were edentulous for a period less than 1 year, history of irradiation in the
head and neck area, history of reconstructive pre-prosthetic surgery or previous implant
surgery. Five patients were treated
Interventions Two-stage sinus lift with autogenous blocks and particulate bone together with buccal
onlays monocortico-cancellous bone grafts, to reconstruct the width of the maxilla, fixed
with titanium screws harvested from the iliac crest with or without PRP left to heal for 3
months in a split-mouth trial. Barriers were not used. PRP was made using the Platelet
ConcentrationCollection System kit (PCCS kit, 3i Implant Innovations Inc. PalmBeach
Gardens, FL, USA). 54 ml of blood were mixed with 6 ml of anticoagulant (citrate
dextrose) and processed with the platelet concentration system. To promote the release
of growth factors from the platelets, 10% calcium chloride solution and the patient’s
serum, as a source of autologous thrombin, were added before actual reconstruction of
the defect with the bone graft. The resulting gel was mixed with the bone graft and some
gel was applied at the closure of the wound at the side treated with PRP. Three implants
were inserted into the healed graft of each side and were left to heal for an additional
6 months. All the augmentation procedures were performed under general anaesthesia.
Surgical templates were used to optimise implant insertion. All implants were turned
titanium self tapping (Nobel Biocare, Göteborg, Sweden) and were rehabilitated with
two implant-supported prostheses
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Raghoebar 2005 (Continued)
Outcomes Prosthesis and implant failure. Complications at the augmented and donor sites. Histo-
morphometrical evaluation
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: No information presented.
Author’s reply: “Randomisation by lot”.
Allocation concealment? Unclear Article: No information presented.
Author’s reply failed to clarify the issue.
Blinding?
All outcomes
Yes Article: “The investigators were blinded for
both the clinical and laboratory investiga-
tions with regard to the PRP-treated side”
Incomplete outcome data addressed?
All outcomes
Yes All data presented, no drop outs.
Free of selective reporting? Yes
Free of other bias? Unclear Author: “The apparatus was gift from the
company promoting the use of PRP”
This was considered to be irrelevant.
In all patients additional buccal onlays
were performed meaning that these pa-
tients might have not been the ideal candi-
dates for the hypothesis tested. It is there-
fore more difficult to interpret the results
since the role of the additional buccal on-
lays on the final outcome cannot be quan-
tified
Schaaf 2008
Methods Randomised, split-mouth study with follow-up to abutment connection. No with-
drawals. Data from patients treated according to a parallel group design were not pro-
vided or sought
Participants Severe atrophy of the edentulous or partially edentulous posterior maxilla and intention
to treat with onlay bone blocks and sinus floor augmentation. Residual bone height
values appears to be in the range of 1 to 12 mm according to the measurements kindly
provided by the authors. Adults treated at university clinics of Giessen and Herlangen
(Germany). Patients were excluded if they had blood platelet disorders, haemorrhagic
diathesis or medication with aspirin before surgery, infectious diseases such as hepatitis,
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Schaaf 2008 (Continued)
malignancy, radiotherapy, severe osteoporosis, drug addition, and ineligibility to donate
blood. 34 patients enrolled in the split-mouth study
Interventions Two-stage sinus lift with lateral window approach using either autogenous particulate
bone from the iliac crest alone or the same graft plus PRP. All sites were also horizontally
augmented with corticospongeous blocks from the iliac crest fixed with screws. PRP was
produced at the university Institutes of Clinical Immunology and Transfusion Medicine
under transfusion medical standards. Autologous platelet concentrate from PRP derived
from 450 ml CPD-anticoagulated blood. The PRP was concentrated using differential
centrifugation, then stored for 24 h and adjusted up to 1010 platelets/ml. The concen-
trations obtained were 11-12 times above the baseline level of whole blood. All augmen-
tation procedures were performed under general anaesthesia. After 4 months of healing,
different implant systems (no details provided) were inserted and left to heal submerged
for 6 months
Outcomes Implant failures. Complications at augmented sites. Histomorphometrical evaluation.
Radiographic evaluation of bone height at the level of the former first molar at the
lowest point of the sinus on panoramic radiographs taken pre-operatively, just after
augmentation, and after implant placement. Bone density on CT scans taken 4 months
after augmentation
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: No information presented.
Author’s reply: “Randomisationprocess has
been performed by our department for
medical statistics. They gave us a numbered
randomisation data sheet. Every time we
had a patient who fulfilled the inclusion
criteria he got the next number on the list
in strict sequence. The number on the list
then told us in which group the patient has
to be”
Allocation concealment? No Article: No information presented.
Author’s reply: “The surgeon knows 1 day
prior to the operation,when the study coor-
dinator looked up the randomisation num-
ber”
Blinding?
All outcomes
Yes Article: “Patients, as well as the immunol-
ogist involved in the PRP preparation and
the examining pathologist, were blinded to
the treatment”
Author’s reply: “The outcome assessor was
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blinded to the belonging of the group,
whether PRP was used or not”
Incomplete outcome data addressed?
All outcomes
No Not complete radiographic and data pre-
sented or supplied so we were unable to use
part of the data
Free of selective reporting? Yes
Free of other bias? Unclear In all patients additional buccal onlays
were performed meaning that these pa-
tients might have not been the ideal candi-
dates for the hypothesis tested. It is there-
fore more difficult to interpret the results
since the role of the additional buccal on-
lays on the final outcome cannot be quan-
tified
Szabó 2005
Methods Randomised, split-mouth study with follow-up to implant loading. No withdrawals
Participants Edentulous patients having less than 5 mm of alveolar bone in the floor of the sinus.
Adults treated at university hospitals in Budapest (Hungary), Manchester (UK), Milan
(Italy) and in a private practice in Bruges (Belgium). No specific exclusion criteria were
given and patients were healthy and had no disease that might influence the treatment
outcome. 20 patients enrolled
Interventions Two-stage sinus lift with autogenous particulate bone from the iliac crest versus two-stage
sinus lift with 1.5 to 2 gbeta-tricalciumphosphate (Cerasorb,CurasanAG,Kleinostheim,
Germany) left healing for 6 months. In 10 of the 20 patients the alveolar crest was
also widened with cortical bone blocks fixed with microscrews. No membranes were
used to cover the bone. All the augmentation procedures were performed under general
anaesthesia. Patients were instructed not to wear any dentures for 30 days. In 16 patients
Ankylos (Degussa, Friadent, Germany) implants were used, whereas in four patients
Protetim (Hungary) implants were used. The authors did no provide any explanation
for using two different implant systems. Two implants were placed in each augmented
sinus
Outcomes Implant failure at abutment connection. Post-operative complications at the grafted site
and at the donor site. Panoramic and computer tomographic imagines (CT images in
10 patients only) to provide a qualitative description of the consolidation of the grafts.
Histomorphometrical assessment of cylindrical bone biopsies
Notes
Risk of bias
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Item Authors’ judgement Description
Adequate sequence generation? Unclear Article: “The choice of sides was random-
ized using the coin-toss method”
One author fromone of the centres replied:
“Centralised randomization with code in a
sealed envelope”
Allocation concealment? Unclear Article: No information presented.
One author fromone of the centres replied:
“Sealed envelopes opened just before plac-
ing the graft into the sinus”
Blinding?
All outcomes
No Article: No information presented.
Author’s reply: “No blinding was used”.
Incomplete outcome data addressed?
All outcomes
No No radiographic data presented.
Free of other bias? No Author informed us that they received free
bone substitutes.
This is considered to be irrelevant.
In 10 patients additional buccal onlays
were performed meaning that these pa-
tients might have not been the ideal candi-
dates for the hypothesis tested. It is there-
fore more difficult to interpret the results
since the role of the additional buccal on-
lays on the final outcome cannot be quan-
tified
Torres 2009
Methods Randomised hybrid study design combining patients with a split-mouth study design
with patients treated according to a quasi-random parallel group design with follow-up
to 2 years after loading. No withdrawals
Participants Patients having less than 7 mm of alveolar bone at the floor of the sinus. Adults treated
at private clinic in Madrid, Spain. Exclusion criteria were severe systemic diseases (ASA
score 3 or more), a previous history of chronic sinusitis. 57 patients were treated
Interventions One or two-stage sinus lift procedures using a lateral window technique and 100%
granular Bio-Oss with or without PRP, left to heal for 6 months. Patients having up
to 4 mm of residual bone height were augmented first and implant were placed after
6 months whereas patients with residual bone more than 4 mm up to 7 mm received
implants during the sinus lift procedures. Implants were left to heal unloaded for 6
months. 10 to 20 cc of venous blood were collected 30 minutes prior to the surgery
and mixed with a 3.8% sodium citrate solution at a 5/1 ratio, achieving anticoagulation
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through calcium binding. The blood was then centrifuged into three and separated into
three layers: red blood cells (RBCs), PRP and poor plasma. Flow cytometry was used for
platelet counting. Platelets counts were 2.97 + 0.7-fold over peripheral blood. PRP was
activated with 30%CaCl2 solution and a PRP gel was obtained and mixed with Bio-Oss.
The entire bone of the buccal window was removed, and after the sinus was filled with
the bone substitute no barrier was used to seal the windows. Patients were instructed
not to wear their upper dentures for 2-3 weeks after surgery. Osseotite (Biomet 3I, Palm
Beach, FL, USA) implants were used
Outcomes Prosthetic and implant failures. Partial loss of the graft and complications. Histomor-
phometrical evaluation
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Article: “..randomized sequence was per-
formed by a computerized randomnumber
generated using GraphPadQuickCalc soft-
ware (GraphPad Software Inc., La Joya, Ca,
USA), including the concealment of the al-
location schedule until the assignment was
done”
Allocation concealment? Yes Article: “Patients included in the inter-
patient clinical trial were allocated by a
blinded assistant into two groups: the first
was to be treated with ABB alone, and the
second with ABB + PRP”
Blinding?
All outcomes
Yes Article: “The surgeon was blinded to the
graft material applied to each patient be-
fore graft implantation. An assistant han-
dled PRP-ABB or the ABB group after the
surgeon had already accessed the sinus and
elevated membrane. The histologist was
blinded to the samples’ groups throughout
the histomorphometric analysis”
Author’s reply: “Implant stability was as-
sessed manually with removed prostheses
and mobile implants were considered as
failures and this evaluation was done by a
prosthodontist who was not aware of study
groups”
Incomplete outcome data addressed?
All outcomes
Unclear We could only evaluate those data kindly
provided by the authors
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Free of selective reporting? Yes
Free of other bias? No Amixed split-mouth and parallel group de-
sign was used: patients requiring augmen-
tation at bilateral sinuses were randomised
in a split-mouth study designwhereas those
requiring unilateral sinus lift sinus were al-
ternated in a quasi-random study design.
We have not included data from the quasi-
random study
Wannfors 2000
Methods Randomised trial of parallel groupdesign, 3-year post-loading follow-up.Nowithdrawals
at 3 years though three patients in the one-stage group refused consent to remove the
prostheses for testing implant stability
Participants Edentulous patients with more than 2mm but less than 7mm of residual bone under the
maxillary sinuses. Adults treated under general anaesthesia at the Karolinska Hospital,
Stockholm, Sweden. Patients were included if they were edentulous in the upper jaw.
Patients were excluded if they were older than 80 years, had pathologies in the maxillary
sinus, had bone diseases or took medications known to effect bone metabolism (i.e.
corticosteroids and bisphosphonates). 40 patients enrolled, 20 in each group
Interventions One-stage sinus lift with monocortical iliac bone blocks fixed usually with two implants
left to heal for 6 months versus two-stage sinus lift with particulate bone from the iliac
crest left to heal for 6 months and then usually two implants were inserted into the
healed graft and were left to heal for an additional 6 months. All implants were titanium
self tapping (Brånemark System, Nobel Biocare)
Outcomes Prosthesis failure, implant failure and marginal bone level changes on intraoral radio-
graphs taken with a paralleling technique at abutment connection, 1 and 3 years. Intra-
operative sinus membrane perforations
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Article: “He (patient) was allotted to one
of the two treatments according to a previ-
ously designed scheme by a third person”
Author’s reply: “The randomization was
performed by a third person without any
beforehand contact with the patients”
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Allocation concealment? Unclear Article: No information presented.
Author’s reply failed to clarify the issue.
Blinding?
All outcomes
No Article: No information presented.
Author’s reply: “The outcome assessor had
knowledge of the randomized group, how-
ever not when assessing the x-ray data”
Incomplete outcome data addressed?
All outcomes
No Full data of complications not provided.
Free of selective reporting? No Full data of complications not provided.
Free of other bias? Yes
PRP - platelet-rich plasma
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aimetti 2008 The article presented data from four patients treated following a split-mouth design. Authors informed us that
they actually treated 16 patients. We are unable to present the data for the remaining 12 patients
Barone 2005 No clinical outcome measures related to implant treatment.
Barone 2008 Insufficient follow-up time with no clinical outcome measures related to implant treatment
Boyne 2005 Described as RCT, unclear number of patients, unequal number of patients in the treatment groups. No reply to
letter
Choi 2009 No clinical outcome measures related to implant treatment.
Consolo 2007 No clinical outcome measures related to implant treatment.
Cordaro 2008 No clinical outcome measures related to implant treatment.
Crespi 2009 No clinical outcome measures related to implant treatment.
Froum 1998 Described as RCT, unclear number of patients and tested interventions which seem to be much more than eight,
unequal number of patients in the treatment groups. No reply to letter
Froum 2006 No clinical outcome measures related to implant treatment.
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Froum 2008 No clinical outcome measures related to implant treatment.
Hallman 2008 No clinical outcome measures related to implant treatment.
Kassolis 2005 No clinical outcome measures related to implant treatment.
Kim 2009 No clinical outcome measures related to implant treatment.
Mangano 2007 The authors informed us that the trial was not an RCT but a CCT
Steigmann 2005 No clinical outcome measures related to implant treatment.
Suba 2006 No clinical outcome measures related to implant treatment.
Tawil 2001 Inappropriate study design, neither parallel group nor split-mouth
Triplett 2009 Unclear how many patients were randomised to each group, data very confused and we were unable to retrieve
sufficient data from the original publication. No reply to letter
CCT - controlled clinical trial
RCT - randomised controlled clinical trial
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